| Men (n = 85) | Women (n = 70) | P value |
---|---|---|---|
Group, n (%) | Â | Â | 0.220 |
 LSI | 28 (32.94%) | 25 (35.71%) |  |
 PGZ + LSI | 22 (25.88%) | 25 (35.71%) |  |
 BBR + LSI | 35 (41.18%) | 20 (28.57%) |  |
Age (age) | 49.62 ± 10.81 | 53.47 ± 7.68 | 0.013 |
Smoking, n (%) | 23 (27.06%) | 2 (2.86%) | < 0.001 |
Drinking, n (%) | 25 (29.41%) | 1 (1.43%) | < 0.001 |
Glucose metabolism | Â | Â | 0.643 |
 IGR, n (%) | 42 (49.41%) | 37 (52.86%) |  |
 T2DM, n (%) | 43 (50.59%) | 33 (47.14%) | |
Treatment adherence (%) | 100 (15–100) | 100 (32–100) | 0.161 |
Baseline BMI (kg/m2) | 28.0 ± 3.5 | 27.4 ± 4.0 | 0.301 |
Final BMI (kg/m2) | 27.0 ± 3.1 | 26.5 ± 4.1 | 0.466 |
BMI changes (kg/m2) | − 1.1 ± 1.1a | − 0.9 ± 1.1a | 0.270 |
Baseline LFC (%) | 33.02 ± 13.70 | 36.01 ± 16.21 | 0.215 |
Final LFC (%) | 19.65 ± 12.65 | 21.76 ± 15.79 | 0.357 |
Absolute changes of LFC (%) | − 13.35 ± 15.41a | − 14.27 ± 15.58a | 0.714 |
 LSI (n = 53) | − 12.64 ± 17.78a | − 8.76 ± 13.49a | 0.379 |
 PGZ + LSI (n = 47) | − 9.95 ± 15.18a | − 15.24 ± 14.54a | 0.229 |
 BBR + LSI (n = 55) | − 16.06 ± 13.35a | − 19.95 ± 17.59a | 0.359 |